Serum phosphate
Role of serum phosphate level in cardiovascular events in non-CKD patients
5
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis
13
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
9
Serum phosphate and phosphate-regulatory hormones in COPD patients
7
Experimental Studies of the Mechanisms Producing Hypocalcemia in Hypernatremic States
7
Phosphate management in chronic kidney disease: is it just about the diary foods?
10
Serum calcium and phosphate level alterations in metabolic syndrome
5
FGF23-Klotho axis in CKD
5
A Comparative Study on Effectiveness of Ferric Citrate Versus Sevelamer Plus Iron Supplement in Patients with Chronic Kidney Disease
5
Escherichia coli Sepsis and Prolonged Hypophosphatemia Following Exertional Heat Stroke
5
Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels
8
Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients
7
Serum lactate and phosphate as biomarkers of intestinal ischemia in a Ugandan tertiary hospital: a cross-sectional study
7
A hemodialysis patient with bone disease after pregnancy: a case report
7
<p>Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis</p>
10
Concentration of Calcium and Phosphate Serum Following Administration of Zinc in Friesian Holstein Bulls
6
FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
12
Bone and soft tissue changes with oral phosphate supplements
8
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
21
The Correlation between the Biomarkers of Bone and Mineral Disorders in patients with CKD stage 4 and stage 5 patients not on dialysis
9